Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
0.6936
+0.0137 (2.02%)
Jun 29, 2026, 9:55 AM EDT - Market open
Skye Bioscience Employees
Skye Bioscience had 2 employees as of March 31, 2026. The number of employees decreased by 10 or -83.33% since the number was last reported on December 31, 2025.
Employees
2
Change
-10
Growth
-83.33%
Revenue / Employee
n/a
Profits / Employee
-$28,665,428
Market Cap
24.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 2 | -10 | -83.33% |
| Dec 31, 2025 | 12 | -4 | -25.00% |
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| IGC Pharma | 70 |
| Evaxion | 46 |
| Longeveron | 38 |
| Quantum BioPharma | 17 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
| VYNE Therapeutics | 10 |
SKYE News
- 4 weeks ago - Skye Bioscience Transcript: AGM 2026 - Transcripts
- 5 weeks ago - Skye Announces Cohort Review Committee Approved Opening of Cohort 2 Based on Favorable Safety Data from First Four Participants Treated in Cohort 1 - GlobeNewsWire
- 6 weeks ago - UPDATE – Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Skye Bioscience price target lowered to $6 from $13 at Piper Sandler - TheFly
- 6 weeks ago - Skye Bioscience reports Q1 EPS (32c), consensus (32c) - TheFly
- 6 weeks ago - Skye Bioscience Reports First Quarter 2026 Financial Results and Business Update - GlobeNewsWire
- 6 weeks ago - Skye Bioscience Quarterly report: Q1 2026 - Filings
- 6 weeks ago - Skye Bioscience Earnings release: Q1 2026 - Filings